95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Clinical trial NCT05631028 · COMPLETED

Trial details

NCT number: NCT05631028
Sponsor: Shiyou Wei
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer Anesthesia Induction

Start date: 2022-12-01
Primary completion: 2022-12-30
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.